Predict recurrence and progression in NMIBC.
Loading...
Found this tool helpful? Share it with your friends!
The EORTC Bladder Risk tool is an essential clinical prediction model designed to estimate the probability of recurrence and progression in patients diagnosed with Non-Muscle Invasive Bladder Cancer (NMIBC). It provides robust risk stratification by utilizing a validated scoring system based on key clinical and pathological factors. This tool is invaluable for urologists and oncologists, enabling them to make informed decisions regarding patient management, surveillance protocols, and treatment strategies. By offering individualized risk assessment, it facilitates precise patient counseling and supports shared decision-making, ultimately optimizing care and improving outcomes for NMIBC patients.